Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Irani

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Current Opinion in Neurology|June 5, 2002
How much control does the brain exert over the immune system?David N Irani
Journal of Clinical & Cellular Immunology|June 13, 2017
Regulated Production of CXCL13 within the Central Nervous SystemDavid N Irani
Seminars in Clinical Neuropsychiatry|February 5, 2003
The classic and variant forms of Creutzfeldt-Jakob diseaseDavid N Irani
Neurologic Clinics|July 29, 2008
Aseptic meningitis and viral myelitisDavid N Irani
Annals of Clinical and Translational Neurology|February 8, 2017
Cerebrospinal fluid protein carbonylation identifies oxidative damage in autoimmune demyelinationDavid N Irani
Annual Review of Medicine|January 15, 2003
Diagnosis and prevention of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob diseaseDavid N Irani, Richard T Johnson
Advances in Neuroimmune Biology|February 9, 2016
Targeting CXCL13 During NeuroinflammationAmanda K Huber, David N Irani
Experimental Neurology|April 27, 2007
The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitisNatalie A Prow, David N Irani
Journal of Neuropathology and Experimental Neurology|June 6, 2007
Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitisDavid N Irani, Natalie A Prow
Frontiers in Oncology|May 15, 2015
Is the concept of central nervous system immune privilege irrelevant in the setting of acute infection?Amanda K Huber, David N Irani
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Current Opinion in Neurology|June 5, 2002
How much control does the brain exert over the immune system?David N Irani
Journal of Clinical & Cellular Immunology|June 13, 2017
Regulated Production of CXCL13 within the Central Nervous SystemDavid N Irani
Seminars in Clinical Neuropsychiatry|February 5, 2003
The classic and variant forms of Creutzfeldt-Jakob diseaseDavid N Irani
Neurologic Clinics|July 29, 2008
Aseptic meningitis and viral myelitisDavid N Irani
Annals of Clinical and Translational Neurology|February 8, 2017
Cerebrospinal fluid protein carbonylation identifies oxidative damage in autoimmune demyelinationDavid N Irani
Annual Review of Medicine|January 15, 2003
Diagnosis and prevention of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob diseaseDavid N Irani, Richard T Johnson
Advances in Neuroimmune Biology|February 9, 2016
Targeting CXCL13 During NeuroinflammationAmanda K Huber, David N Irani
Experimental Neurology|April 27, 2007
The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitisNatalie A Prow, David N Irani
Journal of Neuropathology and Experimental Neurology|June 6, 2007
Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitisDavid N Irani, Natalie A Prow
Frontiers in Oncology|May 15, 2015
Is the concept of central nervous system immune privilege irrelevant in the setting of acute infection?Amanda K Huber, David N Irani
Pageof 5